Birmingham Hematology Oncology Associates, LLC

Birmingham, Alabama 35223

0 studies enrolling now · 5 studies all time

What they study most

Hormone-Refractory Prostate Cancer, MPN (Myeloproliferative Neoplasms), Melanoma, Metastatic Breast Cancer, Prostate Cancer

Studies at this site

• An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis — Completed
• Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer — Completed
• Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma — Stopped early
• Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients — Completed
• DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) — Stopped early